We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+14.34%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$5.11B
AUM Growth
+$508M
Cap. Flow
+$71.5M
Cap. Flow %
1.4%
Top 10 Hldgs %
29.75%
Holding
158
New
25
Increased
53
Reduced
18
Closed
16

Top Buys

Rank Stock Value
1
ECL icon
Ecolab
ECL
+$46M
2
ANNX icon
Annexon
ANNX
+$41.6M
3
CTAS icon
Cintas
CTAS
+$41M
4
GTM
ZoomInfo Technologies
GTM
+$40.9M
5
FRLN
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
+$39.2M

Top Sells

Rank Stock Value
1
AIMT
Aimmune Therapeutics
AIMT
+$53.4M
2
LII icon
Lennox International
LII
+$42.7M
3
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
+$40.3M
4
SPLK
Splunk Inc
SPLK
+$39.6M
5
ZGNX
Zogenix, Inc.
ZGNX
+$32.7M

Sector Composition

Rank Sector Weight
1 Healthcare 40.89%
2 Technology 24.02%
3 Industrials 10.32%
4 Consumer Discretionary 8.24%
5 Communication Services 4.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASND icon
1
Ascendis Pharma A/S
ASND
$16.5B
$264M 5.17%
1,709,848
– –
EXAS
2
DELISTED
Exact Sciences
EXAS
$177M 3.47%
1,740,000
– –
W icon
3
Wayfair
W
$11.9B
$168M 3.28%
576,184
+3,184
+0.6% +$871K
TTD icon
4
Trade Desk
TTD
$8.59B
$156M 3.06%
3,014,840
+14,840
+0.5% +$678K
FIVN icon
5
FIVE9
FIVN
$2.12B
$150M 2.94%
1,159,035
+8,035
+0.7% +$966K
CRWD icon
6
CrowdStrike
CRWD
$189B
$137M 2.67%
3,978,540
+30,540
+0.8% +$890K
SRPT icon
7
Sarepta Therapeutics
SRPT
$1.64B
$131M 2.56%
931,512
-64,488
-6% -$9.8M
BHVN
8
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$116M 2.27%
1,783,761
– –
IGV icon
9
PUT
iShares Expanded Tech-Software Sector ETF
IGV
$12.5B
$113M 2.2%
2,400,000
-600,000
-20% -$36M
DT icon
10
Dynatrace
DT
$12.8B
$109M 2.12%
2,645,050
+795,550
+43% +$32.6M
ROP icon
11
Roper Technologies
ROP
$38.5B
$100M 1.96%
253,200
+20,800
+9% +$8.65M
TWLO icon
12
Twilio
TWLO
$29B
$95.9M 1.88%
387,997
+1,997
+0.5% +$492K
MTD icon
13
Mettler-Toledo International
MTD
$27.9B
$87.9M 1.72%
91,000
– –
LOW icon
14
Lowe's Companies
LOW
$118B
$85.3M 1.67%
514,300
-85,600
-14% -$13.2M
MYOK
15
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$84.7M 1.66%
621,000
– –
POOL icon
16
Pool Corp
POOL
$6.95B
$83.6M 1.64%
249,800
+600
+0.2% +$186K
WCN
17
Waste Connections
WCN
$41.9B
$83.5M 1.63%
804,000
– –
IDXX icon
18
Idexx Laboratories
IDXX
$44.1B
$79M 1.55%
201,000
+25,000
+14% +$9.24M
XIFR
19
XPLR Infrastructure LP
XIFR
$1.12B
$76.5M 1.5%
1,275,100
+17,000
+1% +$1.01M
FVRR icon
20
Fiverr
FVRR
$330M
$71.8M 1.41%
516,893
+118,594
+30% +$12.7M
TT icon
21
Trane Technologies
TT
$97.3B
$71.5M 1.4%
590,000
+118,000
+25% +$13.2M
KRTX
22
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$69.7M 1.36%
901,077
– –
HUBS icon
23
HubSpot
HUBS
$11.9B
$68.9M 1.35%
235,672
+3,672
+2% +$963K
LRCX icon
24
Lam Research
LRCX
$372B
$66.9M 1.31%
2,018,060
+8,060
+0.4% +$278K
ODFL icon
25
Old Dominion Freight Line
ODFL
$44.2B
$64.5M 1.26%
713,200
+92,800
+15% +$8.71M
1
2 3 4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q3 2020 Portfolio in Review

As of Q3 2020, Eventide Asset Management held 158 positions worth $5.11B, up 11% from $4.6B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Eventide Asset Management's Q3 2020 filing shows 25 new, 53 increased, 18 reduced and 16 closed positions. Its largest new stake was Ecolab: 230,000 shares worth $46M. The largest sale was Aimmune Therapeutics, an estimated $53.4M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 45% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q3 2020 buy was Ecolab: 230,000 shares worth $46M.
  • Eventide Asset Management added most to Dynatrace in Q3 2020, an estimated $32.6M increase.
  • Eventide Asset Management's biggest Q3 2020 reduction was Lennox International, cutting an estimated $42.7M.
  • Eventide Asset Management fully exited Aimmune Therapeutics in Q3 2020, selling an estimated $53.4M.
  • Eventide Asset Management's ten largest holdings make up 30% of its $5.11B portfolio in Q3 2020.
  • Eventide Asset Management opened 25 new positions and closed 16 in Q3 2020.
  • Eventide Asset Management's portfolio value rose 11% quarter-over-quarter to $5.11B.

Based on Eventide Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.